Bond Bristol Myers-Squibb 4.125% ( US110122CQ99 ) in USD
| Issuer | Bristol Myers-Squibb |
| Market price | |
| Country | United States
|
| ISIN code |
US110122CQ99 ( in USD )
|
| Interest rate | 4.125% per year ( payment 2 times a year) |
| Maturity | 15/06/2039 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 1 995 600 000 USD |
| Cusip | 110122CQ9 |
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) |
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) |
| Next Coupon | 15/06/2026 ( In 128 days ) |
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. Bristol Myers Squibb's US$1,995,600,000 4.125% bonds (CUSIP: 110122CQ9, ISIN: US110122CQ99), maturing June 15, 2039, currently trade at 100% of par value with a minimum trading size of 2,000 bonds, paying semi-annual coupons, and rated A by S&P and A2 by Moody's. |
Français
Italiano
United States